News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,718 Results
Type
Article (21382)
Company Profile (206)
Press Release (624098)
Multimedia
Podcasts (55)
Webinars (14)
Section
Business (212632)
Career Advice (737)
Deals (32122)
Drug Delivery (53)
Drug Development (66355)
Employer Resources (59)
FDA (13866)
Job Trends (11974)
News (303589)
Policy (23704)
Tag
2027 BioCapital Standard (2)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1560)
Accelerated approval (40)
ADA (29)
Adcomms (5)
Allergies (163)
Alliances (47407)
ALS (157)
Alzheimer's disease (1323)
Antibody-drug conjugate (ADC) (452)
Approvals (14650)
Artificial intelligence (746)
ASCO (226)
Autoimmune disease (303)
Automation (61)
Bankruptcy (299)
Belgium (1)
Best Places to Work (9609)
BIO (53)
Biologics (9)
BIOSECURE Act (7)
Biosimilars (145)
BioSpace Insights (99)
Biotechnology (141)
Bispecific (1)
Bladder cancer (192)
Brain cancer (55)
Breast cancer (664)
Cancer (5231)
Cardiovascular disease (417)
Career advice (635)
Career pathing (14)
CAR-T (321)
CDC (15)
CDMO (80)
Celiac Disease (1)
Cell therapy (835)
Cervical cancer (48)
Clinical research (59270)
Collaboration (2136)
Commercialization (5)
Company closure (2)
Compensation (1573)
Complete response letters (43)
COVID-19 (1586)
CRISPR (119)
C-suite (1169)
Cystic fibrosis (116)
Data (7645)
Decentralized trials (2)
Denatured (28)
Depression (126)
Dermatology (82)
Diabetes (492)
Diagnostics (6632)
Digital health (67)
Diversity (7)
Diversity, equity & inclusion (12)
Drug discovery (332)
Drug pricing (28)
Drug shortages (7)
Duchenne muscular dystrophy (211)
Earnings (85172)
Editorial (11)
Employer branding (9)
Employer resources (55)
Events (109950)
Executive appointments (1040)
FDA (17646)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (30)
Funding (1625)
Gene editing (246)
Generative AI (56)
Gene therapy (610)
GLP-1 (549)
Government (1961)
Grass and pollen (4)
Guidances (362)
Healthcare (14674)
Hematology (130)
HIV (74)
Huntington's disease (28)
IgA nephropathy (111)
Immunology and inflammation (153)
Immuno-oncology (82)
Indications (210)
Infectious disease (1877)
Inflammatory bowel disease (162)
Inflation Reduction Act (6)
Influenza (130)
Intellectual property (321)
Interviews (87)
IPO (15077)
IRA (10)
Job creations (2776)
Job search strategy (571)
JPM (23)
Kidney cancer (27)
Labor market (30)
Layoffs (193)
Leadership (8)
Legal (6087)
Licensing (20)
Liver cancer (80)
Longevity (32)
Lung cancer (662)
Lymphoma (370)
Machine learning (60)
Management (22)
Manufacturing (1016)
Marketing (10)
MASH (151)
Medical affairs (2)
Medical device (13786)
Medtech (14038)
Mergers & acquisitions (18384)
Metabolic disorders (1024)
mRNA (209)
Multiple sclerosis (144)
Multispecific (1)
NASH (8)
Netherlands (1)
Neurodegenerative disease (348)
Neuropsychiatric disorders (57)
Neuroscience (2555)
NextGen: Class of 2026 (5103)
Non-profit (2110)
Now hiring (21)
Obesity (345)
Opinion (126)
Ovarian cancer (202)
Pain (225)
Pancreatic cancer (290)
Parkinson's disease (307)
Partnered (27)
Patents (624)
Patient recruitment (745)
Peanut (61)
People (53627)
Peptides (2)
Pharmaceutical (40)
Pharmacy benefit managers (14)
Phase 1 (19363)
Phase 2 (26132)
Phase 3 (18376)
Pipeline (10064)
Policy (83)
Postmarket research (1908)
Preclinical (8326)
Press Release (69)
Prostate cancer (280)
Psychedelics (10)
Radiopharmaceuticals (341)
Rare diseases (824)
Real estate (4908)
Recruiting (25)
Regulatory (20256)
Reports (32)
Research institute (1640)
Resumes & cover letters (111)
Rett syndrome (48)
RNA editing (19)
RSV (67)
Schizophrenia (128)
Series A (293)
Series B (201)
Service/supplier (6)
Sickle cell disease (78)
Special edition (2)
Spinal muscular atrophy (107)
Sponsored (27)
Startups (3343)
State (2)
Stomach cancer (5)
Supply chain (82)
Tariffs (12)
The Weekly (25)
Vaccines (768)
Venture capital (69)
Weight loss (137)
Women's health (112)
Worklife (4)
Date
Today (165)
Last 7 days (522)
Last 30 days (1991)
Last 365 days (25558)
2026 (17922)
2025 (25601)
2024 (30592)
2023 (35208)
2022 (45677)
2021 (49261)
2020 (46220)
2019 (36897)
2018 (27640)
2017 (27657)
2016 (26597)
2015 (33116)
2014 (28008)
2013 (23968)
2012 (25863)
2011 (26249)
2010 (25211)
Location
Africa (466)
Alabama (90)
Alaska (6)
Arizona (374)
Arkansas (16)
Asia (34315)
Australia (5350)
California (14073)
Canada (3813)
China (1235)
Colorado (611)
Connecticut (556)
Delaware (362)
Europe (66350)
Florida (2130)
Georgia (456)
Hawaii (4)
Idaho (60)
Illinois (1062)
India (91)
Indiana (491)
Iowa (24)
Japan (613)
Kansas (128)
Kentucky (48)
Louisiana (44)
Maine (39)
Maryland (1554)
Massachusetts (9883)
Michigan (409)
Minnesota (764)
Mississippi (6)
Missouri (153)
Montana (31)
Nebraska (19)
Nevada (136)
New Hampshire (89)
New Jersey (3413)
New Mexico (28)
New York (3529)
North Carolina (1712)
North Dakota (10)
Northern California (7062)
Ohio (408)
Oklahoma (23)
Oregon (30)
Pennsylvania (2663)
Puerto Rico (28)
Rhode Island (51)
South America (741)
South Carolina (92)
South Dakota (1)
Southern California (5753)
Tennessee (203)
Texas (2310)
United States (48340)
Utah (431)
Vermont (2)
Virginia (241)
Washington D.C. (52)
Washington State (1135)
West Virginia (3)
Wisconsin (153)
Wyoming (2)
645,718 Results for "myos rens technology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc.
MYOS RENS Technology Inc. (“MYOS” or the “Company”) (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin ® , a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced that it has settled its pending litigation with RENS Technology Inc. and its president,
July 16, 2020
·
6 min read
Deals
MedAvail and MYOS RENS Technology Announce Closing of Business Combination
MedAvail, Inc. (“MedAvail”), a leading technology-enabled pharmacy organization that embeds pharmacy services directly into clinics and other points of care through its proprietary technology, announced the completion of its previously announced business combination with MYOS RENS Technology, Inc. (NASDAQ: MYOS), an adva
November 18, 2020
·
5 min read
Deals
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
MYOS RENS Technology Inc. (“MYOS” or the “Company”) (NASDAQ: MYOS) As previously announced, on June 30, 2020 , MYOS RENS Technology, Inc., a Nevada corporation (“MYOS”), and MedAvail, Inc
November 17, 2020
·
7 min read
Press Releases
RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026
September 8, 2026
·
1 min read
Press Releases
Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN wearable for Acute Treatment of Migraine
September 30, 2025
·
5 min read
Pharm Country
MYOS RENS Technology, Inc. Appoints The S3 Agency to Help Build Awareness of Muscle Health Importance
MYOS RENS Technology, Inc. (“MYOS”) (NASDAQ: MYOS), “The Muscle Health Company” and owner of the advanced nutrition supplement Fortetropin®, announced today that it has hired The S3 Agency (S3)
September 9, 2020
·
5 min read
Deals
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a Nevada corporation (“MYOS”), and MedAvail, Inc., a privately-held Delaware corporation (“MedAvail”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”), by and among MYOS, MedAvail,
November 12, 2020
·
7 min read
Business
MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020
MYOS RENS Technology Inc. (“MYOS” or the “Company”) (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin ® , a proprietary bioactive composition that helps build lean muscle, announced today its results fo
November 6, 2020
·
12 min read
Pharm Country
MYOS CORP, Formerly Known as Myos Rens Technology, Inc., Issues Notice to its Shareholders
MYOS CORP (“MYOS” or the “Company”), is a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health . MYOS is the sole owner of Fortetropin ® , a proprietary advanced nutrition product developed and owned by MYOS, that has been shown in multiple veterinary and human cli
December 15, 2020
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
1 of 64,572
Next
